VC Deals Analysis: 2017 Takes Medtech Venture Investing To New High
Executive Summary
Venture-backed medical device and diagnostic companies enjoyed a boon year in 2017, when the annual intake of venture financing dollars hit a five-year high and surpassed the $6bn mark. Helping to give the year's total deal value a boost were several nine-figure deals, including a $900m Series B by Illumina spin-out Grail and others. Medtech Insight takes a look at the VC deal trends in 2017 and what could be ahead in 2018.